These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
669 related articles for article (PubMed ID: 26426537)
1. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537 [TBL] [Abstract][Full Text] [Related]
2. Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance. Lei M; Ma G; Sha S; Wang X; Feng H; Zhu Y; Du X Drug Deliv; 2019 Dec; 26(1):262-272. PubMed ID: 30856352 [TBL] [Abstract][Full Text] [Related]
3. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234 [TBL] [Abstract][Full Text] [Related]
4. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells. Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039 [TBL] [Abstract][Full Text] [Related]
5. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro. Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859 [TBL] [Abstract][Full Text] [Related]
6. TPGS and chondroitin sulfate dual-modified lipid-albumin nanosystem for targeted delivery of chemotherapeutic agent against multidrug-resistant cancer. Luo K; Xu F; Yao T; Zhu J; Yu H; Wang G; Li J Int J Biol Macromol; 2021 Jul; 183():1270-1282. PubMed ID: 34004196 [TBL] [Abstract][Full Text] [Related]
7. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion. Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386 [TBL] [Abstract][Full Text] [Related]
9. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance. Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761 [TBL] [Abstract][Full Text] [Related]
10. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance. Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367 [TBL] [Abstract][Full Text] [Related]
11. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response. Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419 [TBL] [Abstract][Full Text] [Related]
12. iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance. Shen J; Meng Q; Sui H; Yin Q; Zhang Z; Yu H; Li Y Mol Pharm; 2014 Aug; 11(8):2579-91. PubMed ID: 24236909 [TBL] [Abstract][Full Text] [Related]
13. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution. Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562 [TBL] [Abstract][Full Text] [Related]
14. Surface modification of paclitaxel-loaded liposomes using d-α-tocopheryl polyethylene glycol 1000 succinate: Enhanced cellular uptake and cytotoxicity in multidrug resistant breast cancer cells. Han SM; Baek JS; Kim MS; Hwang SJ; Cho CW Chem Phys Lipids; 2018 Jul; 213():39-47. PubMed ID: 29550143 [TBL] [Abstract][Full Text] [Related]
15. Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance. Zhao D; Zhang H; Yang S; He W; Luan Y Int J Pharm; 2016 Dec; 515(1-2):281-292. PubMed ID: 27746331 [TBL] [Abstract][Full Text] [Related]
16. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells. Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697 [TBL] [Abstract][Full Text] [Related]
17. Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors. Wang AT; Liang DS; Liu YJ; Qi XR Biomaterials; 2015 Jun; 53():160-72. PubMed ID: 25890716 [TBL] [Abstract][Full Text] [Related]
18. A novel approach to overcome multidrug resistance: utilization of P-gp mediated efflux of paclitaxel to attack neighboring vascular endothelial cells in tumors. Yoshizawa Y; Ogawara K; Kimura T; Higaki K Eur J Pharm Sci; 2014 Oct; 62():274-80. PubMed ID: 24956463 [TBL] [Abstract][Full Text] [Related]
19. Chemosensitizing micelles self-assembled from amphiphilic TPGS-indomethacin twin drug for significantly synergetic multidrug resistance reversal. Chen R; Wang Z; Wu S; Kuang X; Wang X; Yan G; Tang R J Biomater Appl; 2021 Mar; 35(8):994-1004. PubMed ID: 33283586 [TBL] [Abstract][Full Text] [Related]
20. Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance. Dong K; Yan Y; Wang P; Shi X; Zhang L; Wang K; Xing J; Dong Y Int J Nanomedicine; 2016; 11():5109-5123. PubMed ID: 27785018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]